Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 130 entries
Sorted by: Best Match Show Resources per page
Academic advising and the persistence intentions of community college students in their first weeks in college

community college

Hatch DK, Garcia CE.
GSID: BY_gVn5cPcUJ
DK Hatch, CE Garcia - The Review of Higher Education, 2017 - muse.jhu.edu

… a greater focus on community college classroom practices related to persistence, it remains true that, at least for the first weeks, an entering community college student’s experience is …

Cite
Hatch, D. K., & Garcia, C. E. (2017). Academic advising and the persistence intentions of community college students in their first weeks in college. The Review of Higher Education, 40(3), 353-390.
Hatch, Deryl K., and Crystal E. Garcia. "Academic advising and the persistence intentions of community college students in their first weeks in college." The Review of Higher Education 40.3 (2017): 353-390.
Copy Download .nbib Format: MLA
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections.

Infection and drug resistance

Falci DR, Pasqualotto AC.
PMID: 24187505
Infect Drug Resist. 2013 Oct 22;6:163-74. doi: 10.2147/IDR.S51340.

The triazole class of antifungal drugs comprises first-line agents for the treatment of several invasive fungal diseases. Isavuconazole is a novel broad-spectrum triazole agent. Here we summarize its characteristics and compare it with the currently available antifungal agents. Isavuconazole...

Cite
Falci DR, Pasqualotto AC. Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist. 2013;6:163-74doi: 10.2147/IDR.S51340.
Falci, D. R., & Pasqualotto, A. C. (2013). Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infection and drug resistance, 6163-74. https://doi.org/10.2147/IDR.S51340
Falci, Diego R, and Pasqualotto, Alessandro C. "Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections." Infection and drug resistance vol. 6 (2013): 163-74. doi: https://doi.org/10.2147/IDR.S51340
Falci DR, Pasqualotto AC. Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist. 2013 Oct 22;6:163-74. doi: 10.2147/IDR.S51340. PMID: 24187505; PMCID: PMC3810441.
Copy Download .nbib Format: NLM
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.

Oncotarget

Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R.
PMID: 26405159
Oncotarget. 2015 Sep 15;6(27):24581. doi: 10.18632/oncotarget.5663.

The Abstract is incorrect in PubMed. The corrected Abstract is provided here.

Cite
Janku F, Angenendt P, Tsimberidou AM, et al. Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget. 2015;6(27):24581doi: 10.18632/oncotarget.5663.
Janku, F., Angenendt, P., Tsimberidou, A. M., Fu, S., Naing, A., Falchook, G. S., Hong, D. S., Holley, V. R., Cabrilo, G., Wheler, J. J., Piha-Paul, S. A., Zinner, R. G., Bedikian, A. Y., Overman, M. J., Kee, B. K., Kim, K. B., Kopetz, E. S., Luthra, R., Diehl, F., Meric-Bernstam, F., & Kurzrock, R. (2015). Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget, 6(27), 24581. https://doi.org/10.18632/oncotarget.5663
Janku, Filip, et al. "Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies." Oncotarget vol. 6,27 (2015): 24581. doi: https://doi.org/10.18632/oncotarget.5663
Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R. Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget. 2015 Sep 15;6(27):24581. doi: 10.18632/oncotarget.5663. PMID: 26405159; PMCID: PMC4695208.
Copy Download .nbib Format: NLM
Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience.

Oncoscience

Corrales-Medina FF, Herzog C, Hess K, Egas-Bejar D, Hong DS, Falchook G, Anderson P, Nunez C, Huh WW, Naing A, Tsimberidou AM, Wheler J, Paul SP, Janku F, Kleinerman ES, Kurzrock R, Subbiah V.
PMID: 25587555
Oncoscience. 2014 Jul 27;1(7):522-530. doi: 10.18632/oncoscience.68.

BACKGROUND: Children (patients ≤ 18 years of age) are not usually included on pharmaceutical industry sponsored Phase I trials.METHODS: We reviewed the medical records of 40 patients ≤ 18 years treated in ≥ 1 phase I trial at MD...

Cite
Corrales-Medina FF, Herzog C, Hess K, et al. Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience. Oncoscience. 2014;1(7):522-530doi: 10.18632/oncoscience.68.
Corrales-Medina, F. F., Herzog, C., Hess, K., Egas-Bejar, D., Hong, D. S., Falchook, G., Anderson, P., Nunez, C., Huh, W. W., Naing, A., Tsimberidou, A. M., Wheler, J., Paul, S. P., Janku, F., Kleinerman, E. S., Kurzrock, R., & Subbiah, V. (2014). Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience. Oncoscience, 1(7), 522-530. https://doi.org/10.18632/oncoscience.68
Corrales-Medina, Fernando F, et al. "Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience." Oncoscience vol. 1,7 (2014): 522-530. doi: https://doi.org/10.18632/oncoscience.68
Corrales-Medina FF, Herzog C, Hess K, Egas-Bejar D, Hong DS, Falchook G, Anderson P, Nunez C, Huh WW, Naing A, Tsimberidou AM, Wheler J, Paul SP, Janku F, Kleinerman ES, Kurzrock R, Subbiah V. Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience. Oncoscience. 2014 Jul 27;1(7):522-530. doi: 10.18632/oncoscience.68. PMID: 25587555; PMCID: PMC4278323.
Copy Download .nbib Format: NLM
MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors.

Oncoscience

Tang C, Jardim DL, Falchook GS, Hess K, Fu S, Wheler JJ, Zinner RG, Naing A, Tsimberidou AM, De Melo Galgiato D, Westin SN, Meric-Bernstam F, Kurzrock R, Hong DS.
PMID: 25593979
Oncoscience. 2013 Dec 11;1(1):5-13. doi: 10.18632/oncoscience.3. eCollection 2014.

PURPOSE: MET alterations including amplifications and nucleotide variations have been associated with resistance to therapy and aggressive clinical behavior.EXPERIMENTAL DESIGN: The medical records of patients presenting to the University of Texas MD Anderson Cancer Center Phase I Clinic with...

Cite
Tang C, Jardim DL, Falchook GS, et al. MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors. Oncoscience. 2013;1(1):5-13doi: 10.18632/oncoscience.3.
Tang, C., Jardim, D. L., Falchook, G. S., Hess, K., Fu, S., Wheler, J. J., Zinner, R. G., Naing, A., Tsimberidou, A. M., De Melo Galgiato, D., Westin, S. N., Meric-Bernstam, F., Kurzrock, R., & Hong, D. S. (2014). MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors. Oncoscience, 1(1), 5-13. https://doi.org/10.18632/oncoscience.3
Tang, Chad, et al. "MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors." Oncoscience vol. 1,1 (2014): 5-13. doi: https://doi.org/10.18632/oncoscience.3
Tang C, Jardim DL, Falchook GS, Hess K, Fu S, Wheler JJ, Zinner RG, Naing A, Tsimberidou AM, De Melo Galgiato D, Westin SN, Meric-Bernstam F, Kurzrock R, Hong DS. MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors. Oncoscience. 2013 Dec 11;1(1):5-13. doi: 10.18632/oncoscience.3. eCollection 2014. PMID: 25593979; PMCID: PMC4295762.
Copy Download .nbib Format: NLM
Spatial Variation in the Quality of American Community Survey Estimates.

Demography

Folch DC, Arribas-Bel D, Koschinsky J, Spielman SE.
PMID: 27541024
Demography. 2016 Oct;53(5):1535-1554. doi: 10.1007/s13524-016-0499-1.

Social science research, public and private sector decisions, and allocations of federal resources often rely on data from the American Community Survey (ACS). However, this critical data source has high uncertainty in some of its most frequently used estimates....

Cite
Folch DC, Arribas-Bel D, Koschinsky J, et al. Spatial Variation in the Quality of American Community Survey Estimates. Demography. 2016;53(5):1535-1554doi: 10.1007/s13524-016-0499-1.
Folch, D. C., Arribas-Bel, D., Koschinsky, J., & Spielman, S. E. (2016). Spatial Variation in the Quality of American Community Survey Estimates. Demography, 53(5), 1535-1554. https://doi.org/10.1007/s13524-016-0499-1
Folch, David C, et al. "Spatial Variation in the Quality of American Community Survey Estimates." Demography vol. 53,5 (2016): 1535-1554. doi: https://doi.org/10.1007/s13524-016-0499-1
Folch DC, Arribas-Bel D, Koschinsky J, Spielman SE. Spatial Variation in the Quality of American Community Survey Estimates. Demography. 2016 Oct;53(5):1535-1554. doi: 10.1007/s13524-016-0499-1. PMID: 27541024.
Copy Download .nbib Format: NLM
Intestinal obstruction secondary to primary ileocecal tuberculosis: A case report.

International journal of mycobacteriology

Merza MA, Jabrial FK, Hussein NR.
PMID: 26787063
Int J Mycobacteriol. 2012 Jun;1(2):96-8. doi: 10.1016/j.ijmyco.2012.05.001. Epub 2012 May 26.

A 22-year-old Iraqi male presented with a case of intestinal obstruction secondary to primary ileocecal tuberculosis (TB). The presumptive diagnosis of either Crohn's disease or neoplasm was expected. A right hemicolectomy was performed. Histopathology revealed an inflammatory mass of...

Cite
Merza MA, Jabrial FK, Hussein NR. Intestinal obstruction secondary to primary ileocecal tuberculosis: A case report. Int J Mycobacteriol. 2012;1(2):96-8doi: 10.1016/j.ijmyco.2012.05.001.
Merza, M. A., Jabrial, F. K., & Hussein, N. R. (2012). Intestinal obstruction secondary to primary ileocecal tuberculosis: A case report. International journal of mycobacteriology, 1(2), 96-8. https://doi.org/10.1016/j.ijmyco.2012.05.001
Merza, Muayad A, et al. "Intestinal obstruction secondary to primary ileocecal tuberculosis: A case report." International journal of mycobacteriology vol. 1,2 (2012): 96-8. doi: https://doi.org/10.1016/j.ijmyco.2012.05.001
Merza MA, Jabrial FK, Hussein NR. Intestinal obstruction secondary to primary ileocecal tuberculosis: A case report. Int J Mycobacteriol. 2012 Jun;1(2):96-8. doi: 10.1016/j.ijmyco.2012.05.001. Epub 2012 May 26. PMID: 26787063.
Copy Download .nbib Format: NLM
Symptoms of anxiety and depression: A comparison among patients with different chronic conditions.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Bayat N, Alishiri GH, Salimzadeh A, Izadi M, Saleh DK, Lankarani MM, Assari S.
PMID: 22973345
J Res Med Sci. 2011 Nov;16(11):1441-7.

BACKGROUND: Although patients with chronic diseases are at high-risk for symptoms of anxiety and depression, few studies have compared patients with different chronic conditions in this regard. This study aimed to compare patients with different chronic medical conditions in...

Cite
Bayat N, Alishiri GH, Salimzadeh A, et al. Symptoms of anxiety and depression: A comparison among patients with different chronic conditions. J Res Med Sci. 2011;16(11):1441-7
Bayat, N., Alishiri, G. H., Salimzadeh, A., Izadi, M., Saleh, D. K., Lankarani, M. M., & Assari, S. (2011). Symptoms of anxiety and depression: A comparison among patients with different chronic conditions. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 16(11), 1441-7.
Bayat, Noushin, et al. "Symptoms of anxiety and depression: A comparison among patients with different chronic conditions." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 16,11 (2011): 1441-7.
Bayat N, Alishiri GH, Salimzadeh A, Izadi M, Saleh DK, Lankarani MM, Assari S. Symptoms of anxiety and depression: A comparison among patients with different chronic conditions. J Res Med Sci. 2011 Nov;16(11):1441-7. PMID: 22973345; PMCID: PMC3430061.
Copy Download .nbib Format: NLM
Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Kassaian SE, Alidoosti M, Saleh DK, Zeinali AM, Salarifar M, Sahraian AM, Shirani S, Kazazi EH, Darvish S, Marzban M, Abbasi SH, Massumi A.
PMID: 19737686
EuroIntervention. 2007 May;3(1):60-6.

AIMS: To answer the question whether the delay in coronary artery bypass grafting (CABG) after carotid stenting (CAS) results in adverse events, we describe our experience with planned staged CAS followed by CABG.METHODS AND RESULTS: We retrospectively surveyed our...

Cite
Kassaian SE, Alidoosti M, Saleh DK, et al. Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery. EuroIntervention. 2007;3(1):60-6
Kassaian, S. E., Alidoosti, M., Saleh, D. K., Zeinali, A. M., Salarifar, M., Sahraian, A. M., Shirani, S., Kazazi, E. H., Darvish, S., Marzban, M., Abbasi, S. H., & Massumi, A. (2007). Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3(1), 60-6.
Kassaian, Seyed Ebrahim, et al. "Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 3,1 (2007): 60-6.
Kassaian SE, Alidoosti M, Saleh DK, Zeinali AM, Salarifar M, Sahraian AM, Shirani S, Kazazi EH, Darvish S, Marzban M, Abbasi SH, Massumi A. Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery. EuroIntervention. 2007 May;3(1):60-6. PMID: 19737686.
Copy Download .nbib Format: NLM
Molecular compartmentalization of lateral geniculate nucleus in the gray squirrel (Sciurus carolinensis).

Frontiers in neuroanatomy

Felch DL, Van Hooser SD.
PMID: 22514523
Front Neuroanat. 2012 Apr 10;6:12. doi: 10.3389/fnana.2012.00012. eCollection 2012.

Previous research has suggested that the three physiologically defined relay cell-types in mammalian lateral geniculate nucleus (LGN)-called parvocellular (P), magnocellular (M), and koniocellular (K) cells in primates and X, Y, and W cells in other mammals-each express a unique...

Cite
Felch DL, Van Hooser SD. Molecular compartmentalization of lateral geniculate nucleus in the gray squirrel (Sciurus carolinensis). Front Neuroanat. 2012;6:12doi: 10.3389/fnana.2012.00012.
Felch, D. L., & Van Hooser, S. D. (2012). Molecular compartmentalization of lateral geniculate nucleus in the gray squirrel (Sciurus carolinensis). Frontiers in neuroanatomy, 612. https://doi.org/10.3389/fnana.2012.00012
Felch, Daniel L, and Van Hooser, Stephen D. "Molecular compartmentalization of lateral geniculate nucleus in the gray squirrel (Sciurus carolinensis)." Frontiers in neuroanatomy vol. 6 (2012): 12. doi: https://doi.org/10.3389/fnana.2012.00012
Felch DL, Van Hooser SD. Molecular compartmentalization of lateral geniculate nucleus in the gray squirrel (Sciurus carolinensis). Front Neuroanat. 2012 Apr 10;6:12. doi: 10.3389/fnana.2012.00012. eCollection 2012. PMID: 22514523; PMCID: PMC3322329.
Copy Download .nbib Format: NLM
Behaviour of chromosomes in potato leaf tissue cultured in vitro as studied by BrdC-Giemsa labelling.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Pijnacker LP, Walch K, Ferwerda MA.
PMID: 24248209
Theor Appl Genet. 1986 Sep;72(6):833-9. doi: 10.1007/BF00266554.

Cells of leaf explants of a monohaploid potato (Solanum tuberosum) were stimulated to mitosis on a medium with 5-bromodeoxycytidine during a period of 7 days. The cells cycled with mono- or diplochromosomes which showed differential staining of the sister...

Cite
Pijnacker LP, Walch K, Ferwerda MA. Behaviour of chromosomes in potato leaf tissue cultured in vitro as studied by BrdC-Giemsa labelling. Theor Appl Genet. 1986;72(6):833-9doi: 10.1007/BF00266554.
Pijnacker, L. P., Walch, K., & Ferwerda, M. A. (1986). Behaviour of chromosomes in potato leaf tissue cultured in vitro as studied by BrdC-Giemsa labelling. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 72(6), 833-9. https://doi.org/10.1007/BF00266554
Pijnacker, L P, et al. "Behaviour of chromosomes in potato leaf tissue cultured in vitro as studied by BrdC-Giemsa labelling." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 72,6 (1986): 833-9. doi: https://doi.org/10.1007/BF00266554
Pijnacker LP, Walch K, Ferwerda MA. Behaviour of chromosomes in potato leaf tissue cultured in vitro as studied by BrdC-Giemsa labelling. Theor Appl Genet. 1986 Sep;72(6):833-9. doi: 10.1007/BF00266554. PMID: 24248209.
Copy Download .nbib Format: NLM
What is the appropriate business continuity management staff size?.

Journal of business continuity & emergency planning

Walch D, Merante J.
PMID: 21339110
J Bus Contin Emer Plan. 2008 Apr;2(3):240-50.

This paper explores the question 'how many professionals does it take to build a resilient enterprise?' The paper describes the various segments of a comprehensive business continuity, disaster recovery and crisis management programme and then delves into the variables...

Cite
Walch D, Merante J. What is the appropriate business continuity management staff size?. J Bus Contin Emer Plan. 2008;2(3):240-50
Walch, D., & Merante, J. (2008). What is the appropriate business continuity management staff size?. Journal of business continuity & emergency planning, 2(3), 240-50.
Walch, Damian, and Merante, Jason. "What is the appropriate business continuity management staff size?." Journal of business continuity & emergency planning vol. 2,3 (2008): 240-50.
Walch D, Merante J. What is the appropriate business continuity management staff size?. J Bus Contin Emer Plan. 2008 Apr;2(3):240-50. PMID: 21339110.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 130 entries